Construction of the contingent valuation market in health care: a critical assessment.
about
The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey.Overcoming inherent problems of preference-based techniques for measuring health benefits: an empirical study in the context of kidney transplantation.In Brief: cost-effectiveness analyses in orthopaedicsExploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for MenorrhagiaSystematic Review of Willingness to Pay for Health Insurance in Low and Middle Income Countries.Predictors of willingness to pay for physical activity of socially vulnerable groups in community-based programs.Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, UgandaWillingness to pay for footwear, and associated factors related to podoconiosis in northern Ethiopia.Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis.Contingent valuation: what needs to be done?Sensitivity to scale of willingness-to-pay within the context of menorrhagia.Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents.A Longitudinal Investigation of Willingness to Pay for Health Insurance in Germany.Willingness to pay for adverse drug event regulatory actions.The relationship between reliability and size of willingness-to-pay values: a qualitative insight.Willingness to pay for health insurance among the elderly population in Germany.Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP).Preferences for the normative basis of health care priority setting: some evidence from two countries.Caregivers' willingness-to-pay for Alzheimer's disease medications in Canada.Cancer patients' willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network.Valuing the economic benefits of complex interventions: when maximising health is not sufficient.Valuing a Lifestyle Intervention for Middle Eastern Immigrants at Risk of Diabetes.Resource allocation in NHS dentistry: recognition of societal preferences (RAINDROP): study protocol.Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key
P2860
Q25255918-1D57806D-1B7F-43F8-B2AA-D19D585149C4Q25256695-1B89DF6F-86A9-4F47-9004-44DBFA7797F9Q35078825-58FC9A11-EF17-41F8-9C12-B1BE6DE3E7E6Q36024098-783C292A-6872-4F49-BD35-EBF99152DA75Q36064808-4BFF661A-4C19-4121-A73D-68F04DD7436FQ36074531-B3888E57-A5E5-49BA-8992-6C5A06A6B970Q36647115-D5C7F38D-3018-4993-A883-13323F2CE618Q37291596-B848BE12-885D-4DE6-84EB-137D51463A0BQ37315305-90B26287-A6BA-45A9-8B43-5F26C3F2C203Q37586543-AD8F411B-C212-4A09-8093-EC8E0741E8D9Q37705115-465B9BDA-77EC-4F86-8B88-A697D2B6A5DBQ38211405-69949F91-6F65-4B76-B19A-88B61309F805Q39660783-A7ABE0EE-1F0F-42C4-A6C8-E07565894DC7Q39669274-3CD9D61C-5F24-483F-AC24-A11DCAABB1D0Q39708473-350B0808-2CD8-48AE-9C44-DE21168913F4Q40294727-E9897524-66A9-4D18-B0BA-5DF95C76F1D9Q41666278-C6EFA11A-B0C4-458B-BC34-CF76EBE2BB28Q42360567-B322C42D-F281-4263-B2D1-8C6B65803974Q43761223-245A70F2-2421-40DC-ABB8-18E4E06BBAA5Q44979043-1474D4D1-15CB-4D7E-AB67-475F71F0E086Q45031906-4B6AF142-80F1-4D3F-B735-4D229058BF49Q46601983-E7B29A92-2AD6-4B51-A2DE-7D4BD5CEDD25Q55262056-E17ADD0D-E06F-4815-867A-9A6928B49439Q55417222-457E58FA-0668-40FD-83CE-779208720B84Q57697517-DC37D86A-E2AE-428A-B28B-A35C22917361
P2860
Construction of the contingent valuation market in health care: a critical assessment.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Construction of the contingent valuation market in health care: a critical assessment.
@ast
Construction of the contingent valuation market in health care: a critical assessment.
@en
type
label
Construction of the contingent valuation market in health care: a critical assessment.
@ast
Construction of the contingent valuation market in health care: a critical assessment.
@en
prefLabel
Construction of the contingent valuation market in health care: a critical assessment.
@ast
Construction of the contingent valuation market in health care: a critical assessment.
@en
P356
P1433
P1476
Construction of the contingent valuation market in health care: a critical assessment.
@en
P2093
Richard D Smith
P304
P356
10.1002/HEC.755
P407
P577
2003-08-01T00:00:00Z